Pharmafile Logo

Fresh thinking for the Porterhouse Medical Group


As we embrace 2018, the Porterhouse Medical Group is excited by the potential of our latest subsidiary Porterhouse Insights, a global strategic research, insight and evidence consultancy. The new company offers nimble and agile solutions to global biopharmaceutical companies and is led by Fabrice Allum, an experienced insight professional.

Fabrice has worked in senior roles in the global strategic market research space for a variety of pharmaceutical agencies over the last 20 years or so, and through his experience of these different environments, he has learned that nimble agencies are best placed to meet the changing insight needs of clients.

- PMLiVE

Pharma is at a crossroads as companies look to evolve their business models. Cross-functional working that involves genuine collaboration will maximise knowledge sharing and efficiencies; agencies that reflect this shift will be better able to support clients in this evolution, and offer tangible and impactful solutions. As a Group, we believe we can offer smart medical communications by leveraging research and insight services, as well as providing focused strategies through Porterhouse Insights as a stand-alone practice in its own right, with collaboration at the heart of what we do internally and externally.

Adding Fabrice’s expertise to the award-winning work that Porterhouse Medical has been doing with clients is a great fit, and having him on board brings fresh thinking to the Group.

Please get in touch if you would like to know more about our research and insight services, or how our smarter medical communications could create impact for your brand.

Contact:
Porterhouse Insights: Fabrice@porterhouseinsights.com
Porterhouse Medical Group: Mark@porterhouse.biz

This content was provided by Porterhouse Medical Group